Patients With Upper Gastrointestinal Bleeding in Emergency Department
UGIB-ED
Analysis of the Outcome of Patients With Suspected Upper GI Bleeding Managed in Emergency Departments in Ile de France and External Validation of Prognostic Scores
1 other identifier
observational
2,000
1 country
1
Brief Summary
More than 80% of patients with upper gastrointestinal bleeding (UGIB) are hospitalized after their visit to the emergency department (ED). However, some of these hospitalizations do not seem justified. Several clinical scores have been developed to classify patients according to their risk of death or need for therapeutic intervention. The aims of this study are:
- 1.to describe the characteristics of patients hospitalized for UGIB after their visit to the ED
- 2.to assess the predictive factors of hospital intervention or death
- 3.to assess the accuracy of existing prognostic scores to classify patients according their risk of death or need for therapeutic intervention (external validation) and to identify low-risk patients not requiring intervention.
- 4.Depending on the results, a new score could be derived to identify patients at low risk for intervention or death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedJuly 3, 2023
June 1, 2023
2.1 years
May 11, 2023
June 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of patients treated with specific therapeutic intervention
Blood transfusion or endoscopic hemostasis or radiological hemostasis or surgical hemostasis in 7 days
7 days
Number of deceased patients
30 days
Secondary Outcomes (5)
Number of patients treated with blood transfusion(s)
7 days
Number of patients treated with endoscopic hemostasis
7 days
number of patients treated with endoscopic hemostasis
7 days
number of patients treated with interventional radiology hemostasis
7 days
Death
30 days
Study Arms (1)
Upper gastrointestinal bleeding
Patients with upper gastrointestinal bleeding hospitalized after ED visit
Eligibility Criteria
Patient ≥ 18 years old with a diagnosis of upper gastrointestinal bleeding hospitalized after an ED visit in hospital with data available in the Assistance Publique-Hôpitaux de Paris data warehouse
You may qualify if:
- patient ≥ 18 years old
- with a diagnosis of upper gastrointestinal bleeding (defined by ICD10 codes)
- visited a hospital with ED data available in the data warehouse
You may not qualify if:
- reason for consultation not related to upper gastrointestinal bleeding (identified by manual reading of hospital notes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency department:Saint-Antoine Hospital
Paris, 75012, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre-Clément THIEBAUD, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2023
First Posted
July 3, 2023
Study Start
January 1, 2019
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
July 3, 2023
Record last verified: 2023-06